Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 18;11(14):2234.
doi: 10.3390/cells11142234.

MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma

Affiliations
Review

MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma

Mario Detomas et al. Cells. .

Abstract

Non-coding RNAs (ncRNAs) are a type of genetic material that do not encode proteins but regulate the gene expression at an epigenetic level, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). The role played by ncRNAs in many physiological and pathological processes has gained attention during the last few decades, as they might be useful in the diagnosis, treatment and management of several human disorders, including endocrine and oncological diseases. Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine cancer, still characterized by high mortality and morbidity due to both endocrine and oncological complications. Despite the rarity of this disease, recently, the role of ncRNA has been quite extensively evaluated in ACC. In order to better explore the role of the ncRNA in human ACC, this review summarizes the current knowledge on ncRNA dysregulation in ACC and its potential role in the diagnosis, treatment, and management of this tumor.

Keywords: ACC; adrenocortical adenoma; adrenocortical tumor; lncRNA; miRNA; prognostic markers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflict of interest.

Figures

Figure 1
Figure 1
The image depicts the tumorigenesis pathways in which the principal miRNAs are involved in ACC pathogenesis. Dotted red lines represent the potential pathways regulated by miRNAs evaluated in other types of cancer. Continuous red lines represent the pathways regulated by miRNAs evaluated in ACC models. Image created with BioRender.com.

References

    1. Fassnacht M., Dekkers O.M., Else T., Baudin E., Berruti A., de Krijger R., Haak H.R., Mihai R., Assie G., Terzolo M. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 2018;179:G1–G46. doi: 10.1530/EJE-18-0608. - DOI - PubMed
    1. Altieri B., Ronchi C.L., Kroiss M., Fassnacht M. Next-generation therapies for adrenocortical carcinoma. Best Pract. Res. Clin. Endocrinol. Metab. 2020;34:101434. doi: 10.1016/j.beem.2020.101434. - DOI - PubMed
    1. Giordano T.J., Berney D., de Krijger R.R., Erickson L., Fassnacht M., Mete O., Papathomas T., Papotti M., Sasano H., Thompson L.D.R., et al. Data set for reporting of carcinoma of the adrenal cortex: Explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Hum. Pathol. 2021;110:50–61. doi: 10.1016/j.humpath.2020.10.001. - DOI - PubMed
    1. Mete O., Erickson L.A., Juhlin C.C., de Krijger R.R., Sasano H., Volante M., Papotti M.G. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr. Pathol. 2022;33:155–196. doi: 10.1007/s12022-022-09710-8. - DOI - PMC - PubMed
    1. Mete O., Gucer H., Kefeli M., Asa S.L. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma. Am. J. Surg. Pathol. 2018;42:201–213. doi: 10.1097/PAS.0000000000000943. - DOI - PubMed

Publication types

MeSH terms